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Abstract
A Pathways analysis of the methylamine dehydrogenase^amicyanin^cytochrome c-551i protein electron transfer (ET)
complex predicts two sets of ET pathways of comparable efficiency from the type I copper of amicyanin to the heme of
cytochrome c-551i. In one pathway, the electron exits copper via the Cys92 copper ligand, and in the other, it exits via the
Met98 copper ligand. If the Pathways algorithm is modified to include contributions from the anisotropy of metal^ligand
coupling, independent of differences in copper^ligand bond length, then the pathways via Cys92 are predicted to be at least
100-fold more strongly coupled than the pathways via any of the other copper ligands. All of the favored pathways via Cys92
include a through-space jump from Cys92 to the side chain of Tyr30. To determine whether or not the pathways via Cys92 are
preferentially used for ET, Tyr30 was changed to other amino acid residues by site-directed mutagenesis. Some mutant
proteins were very unstable suggesting a role for Tyr30 in stabilizing the protein structure. Y30F and Y30I mutant amicyanins
could be isolated and analyzed. For the Y30I mutant, the modified Pathways analysis which favors ET via Cys92 predicts a
decrease in ET rate of at least two orders of magnitude, whereas the standard Pathways analysis predicts no change in ET
rate since ET via Met98 is not affected. Experimentally, the ET rates of the Y30I and Y30F mutants were indistinguishable
from that of wild-type amicyanin. Likely explanations for these observations are discussed as are their implications for
predicting pathways for ET reactions of metalloproteins. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Methylamine dehydrogenase (MADH), amicyanin
and cytochrome c-551i from Paracoccus denitri¢cans
form one of the best characterized physiologic elec-
tron transfer (ET) complexes of proteins. It is the
only complex of three soluble redox proteins for
which a high resolution crystal structure is available
[1]. In the crystalline state, the complex catalyzes
methylamine oxidation and subsequent ET from
TTQ to heme via copper, as demonstrated by sub-
strate-dependent spectral changes viewed by single
crystal polarized absorption spectroscopy [2]. The
ET reaction from the type I copper center of amicya-
nin to the heme of the cytochrome within the protein
complex has been studied in solution by stopped-£ow
spectroscopy [3]. Analysis by ET theory [4] of the
temperature dependence of the limiting ¢rst-order
rate constant for the redox reaction yielded values
for the reorganizational energy (V) of 1.1 eV and
electronic coupling (HAB) of 0.3 cm31 associated
with the ET reaction, and predicted an ET distance
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between redox centers which was consistent with the
distance seen in the crystal structure of the complex
[3]. A Pathways analysis [5] of the crystal structure of
the complex revealed that two sets of pathways
(sometimes referred to as pathway tubes) were highly
favored over all other possible pathways between the
redox centers [3]. In one set of pathways, the exit of
electrons from copper occurred via the Cys92 copper
ligand. In the other set of pathways, the exit of elec-
trons from copper occurred via the Met98 copper li-
gand. In this analysis, the coupling for the initial step
of the ET pathway (i.e. from copper to each of its
ligands) was calculated solely based on the distance
that separates them. This analysis does not take into
consideration di¡erences in metal^ligand coupling,
independent of distance, which have been inferred
from quantum chemical calculations and biophysical
studies of the type I copper center [6^8]. If it did,
then that would predict that pathways via the Cys
ligand should be highly favored over those via the
Met ligand [9]. To test whether or not ET from cop-
per does preferentially occur via Cys92, we have used
site-directed mutagenesis to alter Tyr30, a residue
whose side chain is a critical component of all pre-
dicted favored ET pathways to cytochrome c-551i
from which electrons exit the type I copper site via
Cys92.
2. Materials and methods
Previously described procedures were used to pu-
rify MADH [10], amicyanin [11] and cytochrome
c-551i [12] from P. denitri¢cans (ATCC 13543). Pro-
tein concentrations were determined from the previ-
ously reported extinction coe⁄cients for each protein
[11^13]. All reagents were obtained from commercial
sources.
The mauC gene of P. denitri¢cans which encodes
amicyanin was previously cloned into pUC19 to yield
pMEG201 [14]. Site-directed mutagenesis was per-
formed on double stranded pMEG201 using two mu-
tagenic primers with the QuikChange Site-Directed
Mutagenesis Kit (Stratagene). The oligonucleotide
sequences used to construct the site-directed mutants
are as follows: Y30A, 5P-CAAGATGAAAGCCGA-
AACCCCCGAGCTTCATGTCAAG-3P ; Y30F, 5P-
CATCCAAGATGAAATTCGAAACCCCCGAAC-
3P ; Y30H, 5P-GATGAAACACGAAACCCCCGA-
GCTTCATG-3P ; Y30I, 5P-CAAGATGAAAATCG-
AAACCCCCG-3P.
The underlined bases are those which were
changed to create the desired change in the amino
acid sequence. For the Y30F and Y30I mutations,
the change in the nucleotide sequence also generated
a new restriction site which was used to facilitate
screening for the mutation. In the Y30A and Y30H
primers, a second silent mutation (the one closest to
the 3P-end) was introduced to generate a new restric-
tion site to facilitate screening for the mutations. The
sequence of the mauC gene from P. denitri¢cans was
reported by Van Spanning et al. [15]. Mutations were
con¢rmed by dideoxy DNA sequencing of the double
stranded plasmids using the Sequenase Quick-Dena-
ture Plasmid Sequencing Kit (Amersham). For each
mutation, the entire 555-bp mauC-containing frag-
ment was sequenced to ensure that no second site
mutations were present and none was found. Plas-
mids containing the mutated genes were transformed
into Escherichia coli BL21 (DE3) (Novagen) for ex-
pression of amicyanin. Mutant amicyanins were pu-
ri¢ed from the periplasmic fraction of E. coli as
described previously for other amicyanin mutants
[14].
An On-Line Instruments (OLIS, Bogart, GA)
RSM1000 stopped-£ow rapid scanning spectropho-
tometer was used for kinetic measurements. To study
the ET reaction from MADH to amicyanin, one sy-
ringe contained reduced MADH and the other con-
tained oxidized amicyanin. All experiments were per-
formed in 0.01 M potassium phosphate, pH 7.5, at
25‡C. The experimental details and methods of data
analysis have been previously described [14]. To
study the ET reaction from amicyanin to cytochrome
c-551i in the ternary protein complex, one syringe
contained reduced MADH plus reduced amicyanin
at concentrations such that essentially all amicyanin
is in complex with MADH prior to mixing. The oth-
er syringe contained oxidized cytochrome c-551i. All
experiments were performed in 0.01 M potassium
phosphate, pH 7.5, at 25‡C. The experimental details
and methods of data analysis have also been previ-
ously described [3]. The limiting ¢rst order rate con-
stant attributed to the ET reaction (kET) was ob-
tained by ¢tting data to the following model and
equations [3]. The rationale for using this
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MADHred=amicyaninred  cytochromeox
Kd
MADHred=amicyaninred=cytochromeox 
kET
kET
MADHred=amicyaninox=cytochromered 1
kobs  kET cytochromecytochrome  Kd  kET 2
model and reasons for being assured that the spectral
changes that are monitored correspond to the reac-
tion of interest are discussed in detail in our earlier
paper [3]. Non-linear curve ¢tting of data was per-
formed using either OLIS software or Sigma Plot 5.0
(Jandel Scienti¢c). The oxidation^reduction midpoint
potential (Em) values of mutant amicyanins were de-
termined by spectrochemical titration as described
previously [16].
Analysis of protein structures from the crystallo-
graphic coordinates was performed with a Silicon
Graphics Indigo2 computer. Visualization and ma-
nipulation of protein structures was done using the
programs Midas, Quanta and Charmm. ET path-
ways were determined using the Greenpath v.0.97
program [5].
3. Results
3.1. Properties of mutant amicyanins
Of the four site-directed mutants of Tyr30, only the
Y30F and Y30I were expressed and isolated with
yields comparable to the wild-type recombinant ami-
cyanin. Only very low levels (not su⁄cient for use) of
the Y30A mutant amicyanin were detected and the
Y30H mutant amicyanin was not detected at all in
the E. coli expression system. This suggests that ei-
ther the Y30A and Y30H mutant proteins were syn-
thesized, but unusually unstable, or that the muta-
tion a¡ected the synthesis or assembly of the protein.
Tyr30 is an internal amino acid which does not di-
rectly interact with copper and it is not obvious why
these mutations should so dramatically a¡ect expres-
sion. Inspection of the amino acid sequences that
have been determined thus far for amicyanins from
three sources [17^19] indicates that in each protein,
the position corresponding to Tyr30 is either Tyr or
Phe (Table 1). Of the type I copper proteins, amicya-
nin is most similar in sequence to plastocyanin
[17,18]. Inspection of the amino acid sequences of
25 plastocyanins reveals that in each protein, the
position corresponding to Tyr30 is Phe (Table 1).
Thus, the presence of a phenyl side chain on this
residue appears to be important in stabilizing the
structures of these type I copper proteins. It is im-
portant to note that instability need not imply a dif-
ference in structure. For example, the crystal struc-
ture of apoamicyanin is essentially the same as that
of the holoprotein [1,17], despite the fact that it is
much less stable in solution [20].
The Y30F and Y30I mutant amicyanins were ex-
pressed in comparable yields to that of the wild-type
amicyanin and exhibited absorption spectra and Em
values (Table 2) which were indistinguishable from
wild-type amicyanin. The larger error in the Em value
for the Y30I mutant was due to the fact that it was
less stable than the wild-type and Y30F amicyanins
during the relatively long time course (s 1 h) of the
redox titrations. This did not pose a problem in
stopped-£ow experiments because samples were pre-
pared immediately before use in these experiments.
Examination of the redox reactions between oxidized
mutant amicyanins and quinol MADH by stopped-
£ow spectroscopy revealed that the ET rate (kET)
from TTQ of MADH to copper of amicyanin was
essentially the same for the mutants as for wild-type
amicyanin (Table 2). These results strongly suggest
that the Y30F and Y30I mutations caused no signi¢-
cant change in the structure of amicyanin, particu-
larly surrounding the copper binding site.
Table 1
Conservation of Tyr30 in amicyanin and plastocyanin
Source Sequence corresponding
to P. denitri¢cans residues
27^34a
P. denitri¢cans amicyanin [15] K--MKYETPE
T. versutus amicyanin [18] K--MKYLTPE
M. extorquens AM1 amicyanin [19] K--MKFQTPE
Consensus plastocyanin [18] DGSLAFVPSN
aAlignment of primary sequences is based on the numbering for
the P. denitri¢cans amicyanin.
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3.2. ET from mutant amicyanins to cytochrome c-551i
The ET reaction from the copper in mutant ami-
cyanins to the heme of cytochrome c-551i within the
MADH^amicyanin^cytochrome c-551i complex was
studied by stopped-£ow spectroscopy as was previ-
ously done with the wild-type amicyanin [3]. In each
case, a hyperbolic dependence of rate on cytochrome
concentration was observed and the data were ¢t
well to Eq. 2 (not shown). The mutant amicyanins
exhibited Kd values for complex formation with the
cytochrome and ET rate constants which were very
similar to those obtained with the wild-type (Table
2). Thus, these mutations caused no signi¢cant de-
crease in ET e⁄ciency.
3.3. Pathways analysis of wild-type and mutant
complexes
The direct center to center distance from the cop-
per of amicyanin to the iron of cytochrome c-551i in
the crystal structures of the ET complex is 24.7 Aî .
Alternatively, the shortest distance from copper to
the nearest edge of the heme porphyrin ring is 22.7
Aî . A Pathways analysis was performed using the
Greenpath v0.97 computer program [5]. Pathways
from copper to iron and to the porphyrin ring were
calculated and two dominant sets of pathways were
revealed (Fig. 1). In each set of pathways, the point
of intermolecular ET was from the backbone O of
Glu31 of amicyanin to the backbone N of Gly72 of
cytochrome c-551i, and the entry of electrons to iron
occurred either via the porphyrin ring or the His61
ligand. In one set of pathways, the exit of electrons
from copper occurred via the Cys92 copper ligand,
and the phenolic side chain of Tyr30 was an inter-
mediate between Cys92 and Glu31. In the other set of
pathways, the exit of electrons from copper occurred
via the Met98 copper ligand, and the backbone of
Lys29 was an intermediate between Met98 and
Glu31. This analysis does not take into consideration
di¡erences in metal^ligand binding between copper
and the amino acid residues which provide ligands.
Table 2
Properties of wild-type and mutant amicyanins
Amicyanin Em (mV)a kET (s31)b TTQCCu2 Kd (WM)c;d kET (s31)d Cu1Cheme
Wild-type 266 þ 7 4.6 þ 1.5 13 þ 6 85 þ 26
Y30F 267 þ 7 4.8 þ 0.2 9 þ 4 99 þ 30
Y30I 277 þ 12 5.8 þ 0.1 25 þ 11 71 þ 21
aValues are reported relative to the standard hydrogen electrode (SHE).
bThese rates are for the reaction of the dithionite-reduced quinol form of MADH which is known to be rate-limited by ET.
cKd values describe the association of oxidized cytochrome c-551i with the complex of reduced MADH plus reduced amicyanin.
dThese larger errors for the kinetic parameters for the reactions of the ternary protein complex re£ect variation due to di¡erences in
the preparations of the three di¡erent proteins used in the assay, which were typically within þ 45% for Kd and 30% for kET. Stand-
ard errors of the ¢t of data for any given set of experiments were typically within þ 30% for Kd and 10% for kET.
Fig. 1. Predicted pathways of ET between copper and iron
within the MADH^amicyanin^cytochrome c-551i complex. A
portion of the crystal structure of the ternary protein complex
is displayed which shows amino acid residues that comprise the
two most favored sets of predicted pathways. Amicyanin resi-
dues are indicated as A and cytochrome residues are indicated
as C. Portions of the pathways through covalent bonds are
shown as solid gray lines, and through space jumps are shown
as dashed gray lines. The two pathways overlap from Glu31 A
to heme.
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For example, Ullmann and Kostic [9] have reported
a Pathways analysis for possible ET pathways be-
tween iron and copper sites in docked complexes of
cytochrome c and plastocyanin. Consideration of the
anisotropy of metal^ligand coupling, independent of
simply the di¡erences in the metal^ligand distances,
which was based on the electronic structure of the
copper(II) site, was incorporated into their analysis.
Quantum chemical calculations and biophysical stud-
ies [6^8] on which these considerations are based
suggest that the Met ligand of the type 1 copper is
not likely to be involved in ET because the coupling
between copper and Met is essentially zero [9].
The Pathways program calculates the relative e⁄-
ciency of ET pathways according to Eq. 3
HABO2 O i 3
where i ranges over the pathway steps and Oi is a
wave-function decay factor for step i. Pathways
from copper to heme and iron were recalculated tak-
ing into consideration corrections for the anisotropy
of the copper^ligand bonds in amicyanin. The cou-
pling for the initial steps in the ET pathways from
copper to each ligand were scaled by a factor (Q2), as
discussed by Newton [21] to account for relative con-
tributions of each ligand to the redox molecular or-
bitals of the electron donor. Following the approach
taken by Ullmann and Kostic for type I copper pro-
teins [9,22,23], HAB was adjusted to be proportional
to Q2 for these segments of the pathway using values
of Q2 of 0.46 for the Cys92 sulfur ligand, 0.012 for
each of the His95 and His53 nitrogen ligands, and 0
for the Met98 sulfur ligand [9]. A key point is that
these scaling factors are not simply related to the
copper^ligand distances, which are 2.25 Aî to the
Cys92 sulfur, 1.98 Aî to the His53 nitrogen, 1.98 Aî
to the His95 nitrogen, and 2.71 Aî to the Met98 sulfur
[24]. Since all pathways share a common means of
electron donation to the heme iron, it was not neces-
sary to consider this ¢nal step of the pathway when
comparing the relative e⁄ciencies of ET pathways
via the di¡erent copper ligands. The results of these
scaled analyses are presented and compared with the
standard analysis which makes no special provisions
for the anisotropy of metal^ligand interactions other
than di¡erences in metal^ligand distance (Table 3).
According to the ET theory (Eq. 4) [4], kET is
proportional to HAB2, where h is Planck’s
kET  4Z
2HAB2
h

4ZVRT
p exp 3vG  V 2=4VRT  4
constant, and R is the gas constant. Therefore, if
these corrections to account for copper^ligand
bond anisotropy, independent of distance, are incor-
porated into the pathways analysis of the ternary
complex, then pathways in which electrons exit via
Cys92 would be highly favored. The kET via Cys92
would be predicted to be at least 104-fold (i.e.
1/[0.01]2) greater than kET via other ligands (see Ta-
ble 3). In that case, a mutation which selectively dis-
rupts the putative favored pathways from copper to
heme via Cys92 should dramatically decrease the rate
of ET.
Taken together, the very similar absorption spec-
tra, Em values, Kd values for complex formation, and
ET rates from MADH to amicyanin, strongly sug-
gest that the mutations have caused no signi¢cant
change in the amicyanin structure relative to the
wild-type. Thus far, it has not been possible to ob-
tain usable crystals of the Y30I mutant amicyanin
Table 3
Pathways analyses of ET from copper to heme in complexes with wild-type and mutant amicyanins
Electron transfer via Relative HAB
(unscaled)a
Relative predicted kET
(unscaled)
Relative HAB
(scaled by Q2)
Relative predicted kET
(HAB scaled by Q2)
Wild-type Cys92 1.0 1.0 1.0 1.0
Wild-type Met98 2.2 4.8 0 0
Wild-type His53 0.3 0.09 0.01 1U1034
Wild-type His95 0.1 0.01 0.003 9U1036
Y30F Cys95 0.72 0.52 0.72 0.52
Y30I Cys95 0.06 3.6U1033 0.06 3.6U1033
aValues for each column are reported relative to that for the pathway via Cys92 in the wild-type.
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either alone or in complex. This problem may be
related to the relative instability of this mutant pro-
tein which was discussed earlier. To determine the
e¡ects of the Y30F and Y30I mutations on putative
ET pathways, these mutations have been substituted
into the wild-type structure of the ternary protein
complex and Pathways analyses were performed.
The relative couplings (i.e. HAB values) between cop-
per and iron via the Cys92 ligand were determined for
each mutant (Table 3).
The predicted relative coupling for ET via Cys92 in
the Y30F mutant is somewhat weaker than that of
the wild-type (Table 3, Fig. 2). The through-space
jump from Cys92 to the phenyl ring of Phe30 is ap-
proximately 0.7 Aî longer than the jump to the phe-
nolic oxygen of Tyr30 in the wild-type. The pathway
in the wild-type (Fig. 1), however, requires tunneling
through two additional covalent bonds to reach the
equivalent point on the phenyl ring in Tyr30. The
relative predicted coupling of the most e⁄cient pre-
dicted pathway for Y30F which includes this
through-space jump to the phenyl ring of Phe30, is
approximately 72% of that of the wild-type. Thus,
kET in this mutant would be predicted to be approx-
imately 52% of that of the wild-type. A two-fold
change in this rate approaches the limit of discrim-
ination of this experimental system, thus while there
is no apparent e¡ect from the Y30F mutation one
must be cautious in drawing conclusions from these
data. A more de¢nitive result is obtained with the
Y30I mutant.
The relative predicted coupling for ET via Cys92 in
the Y30I mutant is greatly diminished relative to that
of the wild-type (Table 3). This is a consequence of a
signi¢cant increase in distance of approximately 3 Aî
from Cys92 to the Ile side chain relative to that of
Tyr in the wild-type (Fig. 3). Alternative orientations
of Ile are possible in the structure; however, the one
shown is the closest approach that one can model
into the structure. Pathways analysis of the Y30I
structure that incorporates the Y30I mutation indi-
cates that the distance to residue 30 has increased
such that an alternative pathway via Cys92, which
by-passes the long through-space jump, has become
more e⁄cient (Fig. 3). This alternative pathway in-
volves tunneling from Cys92 through His91 and Tyr90,
then jumping to Ile30, and continuing along the re-
mainder of the same pathway that is predicted for
the wild-type. This pathway via Cys92 in the Y30I
mutant exhibits a predicted relative coupling that is
about 17-fold less e⁄cient than of that of the wild-
type. This means that if ET did preferentially occur
via the Cys ligand, then kET should be about 300-
fold less than that of the wild-type and approxi-
Fig. 2. The most e⁄cient predicted pathway of ET via Cys92
after substitution of Phe for Tyr30.
Fig. 3. The most e⁄cient predicted pathway of ET via Cys92
after substitution of Ile for Tyr30.
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mately 150-fold less than that of the Y30F mutant
amicyanin. If ET alternatively occurs via a di¡erent
ligand and the values for relative coupling are scaled
by Q2, a 300-fold reduction in kET would still be pre-
dicted since kET via the other pathways also is pre-
dicted to be at least 104 slower than via Cys92 in the
wild-type (see Table 3). Experimentally, however, no
change is observed.
4. Discussion
When a mutation does not e¡ect an ET rate, one
concern is that the reaction may be gated by a non-
ET event [25,26]. Then variations in the true kET
could be masked. However, if ET from copper to
heme in this complex were a gated reaction then
one would expect the analysis by ET theory to yield
unreasonably large values for V and HAB, and poor
correlation with the true ET distance [26]. In fact,
negative values for the ET distance have been ob-
tained from such an analysis of other interprotein
ET reactions that are known to be gated by adiabatic
reaction steps [27^30]. Results of our previous studies
indicate that the ET reaction from copper to heme in
this protein complex is not gated. Analysis of this
reaction using Eq. 4 [3] yielded an HAB of 0.3
cm31, which is well within the nonadiabatic limit,
and a V of 1.1 eV, which is within the range of values
typically observed for protein ET reactions, particu-
larly those through blue copper proteins [31,32].
That same analysis [3] also predicted an ET distance
between redox centers which approximates that seen
in the crystal structure of the complex.
Another important consideration is the validity of
the crystal structure of the MADH^amicyanin^cyto-
chrome c-551i complex [1] used in the Pathways anal-
ysis. Several lines of evidence point to its relevance.
ET distances predicted from analyses of reactions
from quinol TTQ to copper [33] and from copper
to heme [3] closely match those seen in the crystal
structure. In the crystalline state, the complex cata-
lyzes methylamine oxidation and subsequent ET
from TTQ to heme via copper [2]. The MADH^ami-
cyanin interface which is seen in the crystal structure
has been con¢rmed by site-directed mutagenesis
studies [14]. It should be noted that these Pathways
analyses are performed on the structure that includes
the oxidized type I copper site. However, electronic
[34] and structural [35] studies of reduced type I cop-
per proteins indicate that the relative covalency of
the copper^ligand bonds, especially those to the
Cys and Met ligands, are very similar to what is
seen for the oxidized protein. A ¢nal and unavoid-
able concern is that the isomorphous replacement of
Ile for Tyr30 in the wild structure yields a void in the
structure. This is consistent with the observations
that the mutant protein is less stable than the wild-
type and the mutation to substitute a smaller residue,
Ala, yielded little detectable protein. Inspection of
the mutant structure suggests that although the
void may be large enough to accommodate a water,
there are not su⁄cient ligands present to make this
likely. This raises the possibility that some annealing
of the actual protein might occur and shorten the
prohibitively large gap for ET from Cys to Ile. How-
ever, any such structural perturbations that would
involve Cys30 would be expected to a¡ect the redox
properties of the copper site, and no such e¡ects are
observed.
The uncertainty of how or whether one should
incorporate information about the di¡erences in met-
al^ligand coupling into the Pathways algorithm is
perhaps best demonstrated when considering the
copper^Met interaction in blue copper proteins. If
the probability of ET from copper to the Met sulfur
is scaled to zero, then this pathway segment is being
treated di¡erently from all other through-space
jumps between unbonded atoms in the protein,
each of which have a ¢nite coupling. Our results
suggest that for this experimental system, a standard
Pathways analysis, without correction for anisotropy
of copper^ligand binding other than actual di¡eren-
ces in distance, adequately describes the long range
ET reaction from copper to heme. It is interesting to
note that Gray and coworkers [36] observed that the
ET rates along the Met and Cys L-strands of ruthe-
nium-modi¢ed azurin exhibited a similar distance de-
pendence. Given the anisotropy of the copper^ligand
interactions, one would have expected the electronic
coupling along L-strands which connect the ruthe-
nium to copper via Met or Cys to be quite di¡erent.
An explanation which was proposed to explain those
results is that strong interstrand hydrogen-bond cou-
plings may contribute to the observed apparent sim-
ilarities in coupling via Met and Cys [36]. In other
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words, electrons may cross over from one pathway
to another via a hydrogen bond after preferential exit
from copper via a particular ligand. It is di⁄cult to
rule out the possibility that ET via hydrogen-bonds
between Cys92 and Met98 may also occur in amicya-
nin to allow crossover between pathways after pref-
erential exit of electrons via Cys92. Inspection of the
crystal structure reveals that the Cys92 N and Met98
O are separated by approximately 3.1 Aî . Thus, it
may be possible that electrons could follow the
‘Met pathway’ after exiting copper via Cys92. Inspec-
tion of the structure reveals that such mixed Cys^
Met pathways are still less e⁄cient, with a relative
HAB no greater than 10% of that of either the un-
scaled Met pathway or the scaled wild-type Cys
pathway. This is because the mixed pathways require
ET through several covalent bonds to get from the
Cys92 S to N and then from the Met98 O to the point
on the side chain where it may join the Met pathway.
The mixed pathway is, however, predicted to be
much more e⁄cient than any of the other scaled
pathways via ligands other than Cys92. Thus, it is
important to consider that if e⁄cient crossover be-
tween pathways does occur, it could potentially neg-
ate the signi¢cance of the anisotropy of the copper^
ligand interactions for purposes of using the Path-
ways analysis to predict the most e⁄cient pathways
for long range ET through proteins. The anisotropy
is real, but unless such crossover can be de¢nitively
ruled out or incorporated into the algorithm, then
modi¢cation of the Pathways algorithm to account
for metal^ligand anisotropy may produce misleading
results.
Our new results do not resolve the controversy of
whether protein ET reactions occur via speci¢c path-
ways [5,36] or whether they are described by a simple
distance dependence [37,38] through the relatively
homogeneous protein matrix. It is interesting to
note that a result similar to ours was obtained by
Dohse et al. [39] for the ET from the tetraheme cy-
tochrome to the special pair of bacteriochlorophylls
in the photosynthetic reaction center. A highly con-
served Tyr positioned midway between the two redox
centers was mutated to several di¡erent residues in-
cluding glycine with no signi¢cant disruption of ET.
An alternative interpretation of these and our results
is that they are consistent with this ET reaction obey-
ing a simple distance dependence, independent of
speci¢c pathways, which would be essentially insen-
sitive to any single mutation. Our results do clearly
indicate that if one does apply the Pathways algo-
rithm, one must exercise caution in excluding possi-
ble ET pathways based solely on consideration of the
anisotropy of metal^ligand interactions in type I cop-
per proteins, and in metalloproteins in general.
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